Beximco Pharmaceuticals Ltd.
Additional OffersShow all
Maintenance bronchodilator treatment to relieve symptoms in adult patients with, chronic obstructive pulmonary disease (COPD).
Inhalation The recommended dosage of Glycopyrronium inhalation: One capsule once daily with the ConviHaler device at the same time of day.
Hypersensitivity to the active substance or to any of the excipients.
Mode of Action
Glycopyrronium is a long-acting, specific antimuscarinic agent, in clinical medicine often called an anticholinergic. It has a similar affinity to the s... View More
Glycopyrronium should not be used for the initial treatment of acute episodes of bronchospasm, i.e. rescue therapy. Immediate hypersensitivity reactions... View More
Inhaled medicines may cause inhalation-induced bronchospasm, dehydration, dry mouth, constipation, dizziness, insomnia, skin and subcutaneous tissue dis... View More
Pregnancy Category Note
There is a limited amount of data from the use of Glycopyrronium in pregnant women. Animal studies do not indicate direct or indirect harmful effects wi... View More
Alternative brand for Glyriva Bexicap
The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not... View More